|
WO1994029459A1
(en)
|
1993-06-04 |
1994-12-22 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
|
US5997873A
(en)
*
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US6773707B1
(en)
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
WO1997006821A1
(en)
|
1995-08-18 |
1997-02-27 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
*
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US6130087A
(en)
*
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
JP4484969B2
(ja)
*
|
1996-11-26 |
2010-06-16 |
ヌベンタ バイオファーマスティカル コーポレイション |
ストレスタンパク質を含む組成物を使用する免疫応答
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
*
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
CA2282426A1
(en)
*
|
1997-02-18 |
1998-08-20 |
The Whitehead Institute For Biomedical Research |
Use of heat shock proteins to deliver moieties into cells
|
|
US6709672B2
(en)
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
BE1011033A6
(fr)
|
1997-03-05 |
1999-04-06 |
Univ Bruxelles |
Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
|
|
EP1336621B1
(en)
*
|
1997-08-05 |
2006-05-24 |
Stressgen Biotechnologies Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
AU779770B2
(en)
*
|
1997-08-05 |
2005-02-10 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
KR20060111731A
(ko)
*
|
1997-08-05 |
2006-10-27 |
스트레스젠 바이오테크놀러지스 코포레이션 |
사람 유두종 바이러스 항원과 스트레스 단백질을 포함하는융합 단백질을 포함하는 조성물에 의해 유도된 사람 유두종바이러스 항원에 대한 면역 반응
|
|
AU2005201826B2
(en)
*
|
1997-08-05 |
2008-01-17 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
EP1027070A4
(en)
*
|
1997-10-31 |
2004-08-18 |
Sloan Kettering Institutefor C |
CONJUGATES FROM HEAT SHOCK PROTEIN-BINDING PEPTIDES
|
|
AU1045199A
(en)
*
|
1997-11-05 |
1999-05-24 |
Isis Innovation Limited |
Cancer gene
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
JP4768122B2
(ja)
*
|
1998-02-20 |
2011-09-07 |
ユニバーシティー オブ マイアミ |
改変型熱ショックタンパク質−抗原性ペプチド複合体
|
|
AU5204199A
(en)
*
|
1998-06-12 |
1999-12-30 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Compositions and methods for modulating proteolytic degradation of intracellulartargets
|
|
US6160088A
(en)
*
|
1998-07-29 |
2000-12-12 |
Sloan-Kettering Institute For Cancer |
KDEL receptor inhibitors
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6497880B1
(en)
|
1998-12-08 |
2002-12-24 |
Stressgen Biotechnologies Corporation |
Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
|
|
CA2378097A1
(en)
|
1999-07-08 |
2001-01-18 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
WO2001023421A2
(en)
|
1999-09-30 |
2001-04-05 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
JP2003519668A
(ja)
|
2000-01-14 |
2003-06-24 |
ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ |
熱ショックタンパク質融合タンパク質による、ｃｄ４＋ｔ細胞非依存性のインビボｃｔｌ惹起による個別ａｔｐ結合ドメインのマッピング
|
|
EP1272215B1
(en)
*
|
2000-04-14 |
2007-10-10 |
Intercell AG |
Pharmaceutical preparations comprising modified peptides
|
|
WO2001078772A1
(en)
*
|
2000-04-17 |
2001-10-25 |
Mojave Therapeutics Inc. |
Heat shock protein-based antiviral vaccines
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
DK1296711T3
(da)
|
2000-06-26 |
2006-08-28 |
Stressgen Biotechnologies Corp |
HPV-E7 til behandling af humant papillomavirus
|
|
EP1363938B1
(en)
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
NZ521694A
(en)
|
2002-09-30 |
2005-05-27 |
Co2 Pac Ltd |
Container structure for removal of vacuum pressure
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US6921534B2
(en)
|
2001-02-05 |
2005-07-26 |
Stressgen Biotechnologies Corporation |
Hepatitis B virus treatment
|
|
GB0106161D0
(en)
*
|
2001-03-13 |
2001-05-02 |
King S College London |
Immunomodulators
|
|
US20040043419A1
(en)
*
|
2001-04-17 |
2004-03-04 |
Rothman James E. |
Javelinization of protein antigens to heat shock proteins
|
|
HK1079705A1
(zh)
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
CN1304559C
(zh)
*
|
2001-10-09 |
2007-03-14 |
杭州康科生物技术有限公司 |
表达热休克蛋白的溶瘤微生物及其应用
|
|
WO2003090686A2
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
AU2003300676A1
(en)
*
|
2003-01-03 |
2004-07-29 |
Aurelium Biopharma Inc. |
Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7420037B2
(en)
*
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
GB0303507D0
(en)
*
|
2003-02-14 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
KR20050121721A
(ko)
*
|
2003-04-11 |
2005-12-27 |
안티제닉스 아이엔씨 |
개량된 열 충격 단백질 기초 백신 및 면역치료법
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
US20070059794A1
(en)
*
|
2003-04-28 |
2007-03-15 |
Sekisui Chemical Company Limited |
Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein
|
|
EP1644048B1
(en)
|
2003-05-05 |
2015-04-29 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
DK1625148T3
(da)
|
2003-05-21 |
2013-01-14 |
Biotech Tools Sa |
Peptidkompleks
|
|
EP1479689A1
(en)
*
|
2003-05-21 |
2004-11-24 |
Biotech Tools S.A. |
Peptide complex
|
|
JP2008500006A
(ja)
*
|
2003-05-21 |
2008-01-10 |
バイオテック トゥールス ソシエテ アノニム |
ペプチド複合体
|
|
JP2007505147A
(ja)
|
2003-09-12 |
2007-03-08 |
アンティジェニクス インコーポレーテッド |
単純ヘルペスウイルス感染の治療および予防用ワクチン
|
|
DE60335549D1
(de)
*
|
2003-11-12 |
2011-02-10 |
Alfa Biogene Internat B V |
Gewinnung von Hitzeschockproteinen
|
|
WO2005065418A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
US7449196B2
(en)
*
|
2004-07-09 |
2008-11-11 |
Robert Sabin |
Anti tumor compositions and methods of use
|
|
US20060120995A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Shah Maulik R |
Neoadjuvant genetic compositions and methods
|
|
WO2006073970A2
(en)
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2007050978A2
(en)
*
|
2005-10-29 |
2007-05-03 |
University Of Connecticut |
Methods for the elimination of pathogens and other particulate agents
|
|
WO2007116409A2
(en)
|
2006-04-11 |
2007-10-18 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved vaccines comprising multimeric hsp60 peptide carriers
|
|
US20080081051A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Robert Sabin |
Method of manufacturing anti-tumor and anti-viral compositions
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080311145A1
(en)
*
|
2007-04-04 |
2008-12-18 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
KR20110017356A
(ko)
|
2008-03-20 |
2011-02-21 |
유니버시티 오브 마이애미 |
열충격 단백질 ｇｐ96 백신접종 및 이를 사용하는 방법
|
|
ES2651924T3
(es)
|
2008-04-18 |
2018-01-30 |
The General Hospital Corporation |
Inmunoterapias que emplean vacunas autoensamblantes
|
|
CN102223894A
(zh)
*
|
2008-11-21 |
2011-10-19 |
迈阿密大学 |
用于产生粘膜和系统免疫的hiv/siv疫苗
|
|
EP2270124A1
(en)
*
|
2009-06-30 |
2011-01-05 |
The Procter & Gamble Company |
Bleaching compositions comprising a perfume delivery system
|
|
WO2014093950A1
(en)
|
2012-12-14 |
2014-06-19 |
Virginia Commonwealth University |
Immune modulator for immunotherapy and vaccine formulation
|
|
FR3011850B1
(fr)
*
|
2013-10-15 |
2018-04-06 |
Cfl Biotech |
Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
|
|
BR112017016681A2
(pt)
|
2015-02-06 |
2018-04-10 |
Heat Biologics Inc |
vetor de coexpressão de vacina e moléculas coestimulatórias
|
|
SG10201912485PA
(en)
|
2015-05-13 |
2020-02-27 |
Agenus Inc |
Vaccines for treatment and prevention of cancer
|
|
US20170260286A1
(en)
|
2016-03-10 |
2017-09-14 |
The General Hospital Corporation |
Antigen-Binding Fusion Proteins with Modified HSP70 Domains
|
|
US11666649B2
(en)
|
2016-10-11 |
2023-06-06 |
University Of Miami |
Vectors and vaccine cells for immunity against Zika virus
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
MA52363A
(fr)
|
2018-04-26 |
2021-03-03 |
Agenus Inc |
Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
|
|
EP3965814A4
(en)
*
|
2019-05-10 |
2023-01-11 |
Academia Sinica |
VACCINE COMPRISING A NANOPARTICLE ENCAPSULATING EPITOPES AND AN ADJUVANT, METHOD FOR MAKING IT, AND METHOD FOR NEUTRALIZING A VIRAL INFECTION
|
|
WO2022047248A1
(en)
*
|
2020-08-28 |
2022-03-03 |
Torigen Pharmaceuticals, Inc. |
Immune memory enhanced preparations and uses thereof
|